(CTN News) – On Friday, Eli Lilly announced that it will be investing an additional $5.3 billion in a manufacturing factory that is situated in Lebanon, Indiana. This investment is being made to expand the availability of the company’s highly popular weight loss pharmaceutical, Zepbound, as well as its diabetic treatment, Mounjaro, and other medications. […]

The post Eli Lilly Will Spend $5.3 Billion In Indiana Expanding Mounjaro And Zepbound appeared first on CTN News – Chiang Rai Times.

Go to Source
Author: Salman Ahmad